Issue 000 | U.S. Pilot | US

ENVB

Enveric Biosciences, Inc.

Passing Verified 10-Q | 2026-05-15 Filing currency: USD

Open Filing Back to Register

Margin of Safety 44.3%

GNNI internal calculation. Market context inputs are retained internally and are not displayed.

Current Assets: 5,375,099USD
Total Liabilities: 460,676USD
NCAV: 4,914,423USD
Cash: 4,908,769USD
NCAV per share: needs review
Evidence: 10 annual | 20 quarterly

Business Profile

Checklist-driven facts extracted from filing text. Missing fields stay visible.

Business profile not generated.

Run python -m application.cli.business_profile run --market US --one ENVB, then regenerate the site.

Known Unknowns

Medium | Share Count

Issue 000 does not yet evaluate share count trend or post-filing dilution beyond Mary's screening flags.

Low | Classification

U.S. Pilot rows are surfaced for source inspection and may still need manual business classification review.

Annual Financials

Latest annual periods, newest first. Missing cells render as n/a.

Metric	2025-12-31 10-K USD	2024-12-31 10-K USD	2023-12-31 10-K USD	2022-12-31 10-K USD	2021-12-31 10-K USD	2020-12-31 10-K USD	2019-12-31 10-K USD	2018-12-31 10-K USD	2017-12-31 10-K USD	2016-12-31 10-K USD
Revenue	n/a	n/a	n/a	n/a	n/a	n/a	39,914,675	42,998,280	48,593,712	36,145,589
Operating Income	-8,774,448	-9,632,266	-16,448,440	-27,415,106	-64,623,420	-5,617,317	-6,324,894	-7,146,460	-11,970,689	-5,379,863
Net Income	-8,771,987	-9,574,987	-17,291,732	-18,471,333	-48,976,896	-6,864,676	-5,603,975	-16,897,516	-9,074,813	-2,780,686
Cash From Operations	-8,141,543	-7,726,139	-14,094,411	-17,146,723	-11,457,671	-3,888,785	-2,453,124	-2,565,495	-2,740,794	-2,703,989
Capex	n/a	n/a	-5,180	-584,165	-189,719	n/a	n/a	n/a	n/a	n/a
Free Cash Flow	n/a	n/a	-14,099,591	-17,730,888	-11,647,390	n/a	n/a	n/a	n/a	n/a
Cash And Equivalents	n/a	n/a	n/a	n/a	n/a	n/a	431,400	1,371,331	4,882,084	1,379,887
Accounts Receivable	n/a	n/a	n/a	n/a	n/a	n/a	6,384,148	7,871,422	8,838,453	8,059,910
Inventory	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Current Assets	4,936,707	2,734,584	3,581,531	18,431,937	17,736,837	2,279,170	7,599,154	10,061,353	14,644,803	10,064,942
Total Assets	5,095,941	3,082,543	4,299,840	19,552,925	26,719,133	4,096,891	25,005,152	29,637,450	52,196,628	39,507,923
Total Current Liabilities	918,400	1,489,736	2,343,504	3,995,973	2,083,556	681,250	14,383,605	14,688,965	30,367,882	12,708,952
Total Liabilities	n/a	n/a	n/a	3,995,973	4,413,213	681,250	14,383,605	18,878,353	32,748,445	27,844,220
Shareholders Equity	4,177,541	1,592,807	1,956,336	14,671,924	22,305,920	3,415,641	10,621,547	10,759,097	19,448,183	11,663,703
Shares Outstanding	1,061,533	678,002	2,739,315	2,078,271	32,578,475	10,095,109	2,522,095	42,329,121	18,162,723	13,885,972
Shares Outstanding Diluted	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Weighted Avg Shares Diluted	334,719	502,900	2,159,063	1,446,007	n/a	n/a	2,128,806	23,790,030	14,982,791	13,068,597
Weighted Avg Shares Basic	334,719	502,900	2,159,063	1,446,007	472,343	5,753,598	2,128,806	23,790,030	14,982,791	13,068,597

Quarterly Financials

Latest quarterly periods, newest first. Periods are shown only when Data Vault has them.

Metric	2026-03-31 10-Q USD	2025-12-31 10-K USD	2025-09-30 10-Q USD	2025-06-30 10-Q USD	2025-03-31 10-Q USD	2024-12-31 10-K USD	2024-09-30 10-Q USD	2024-06-30 10-Q USD	2024-03-31 10-Q USD	2023-12-31 10-K USD	2023-09-30 10-Q USD	2023-06-30 10-Q USD	2023-03-31 10-Q USD	2022-12-31 10-K USD	2022-09-30 10-Q USD	2022-06-30 10-Q USD	2022-03-31 10-Q USD	2021-12-31 10-K USD	2021-09-30 10-Q USD	2021-06-30 10-Q USD
Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Operating Income	-1,633,170	-2,193,923	-1,873,943	-2,519,049	-2,187,533	-3,173,826	-2,083,192	-1,897,931	-2,477,317	-2,384,360	-3,448,395	-5,755,007	-4,860,678	-12,255,653	-5,656,849	-4,706,759	-4,795,845	-50,978,543	-3,516,869	-3,363,011
Net Income	-1,633,473	-2,194,171	-1,873,669	-2,519,181	-2,184,966	-3,154,646	-2,084,032	-1,879,394	-2,456,915	-3,435,936	-2,822,216	-6,356,053	-4,677,527	-8,677,902	-2,478,912	-2,790,505	-4,524,014	-42,105,490	-2,712,406	-908,289
Cash From Operations	-2,256,839	-1,784,863	-2,074,956	-1,890,142	-2,391,582	-1,311,549	-927,070	-2,889,173	-2,598,347	-1,751,048	-2,740,433	-4,465,921	-5,137,009	-3,462,117	-4,550,468	-4,585,197	-4,548,941	-4,067,313	-2,206,203	-2,021,877
Capex	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	15	-8	-18	-5,169	-6,193	-18,574	-53,891	-505,507	n/a	n/a	n/a
Free Cash Flow	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-1,751,033	-2,740,441	-4,465,939	-5,142,178	-3,468,310	-4,569,042	-4,639,088	-5,054,448	n/a	n/a	n/a
Cash And Equivalents	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Current Assets	5,375,099	4,936,707	4,165,540	3,307,372	4,834,840	2,734,584	4,338,259	5,519,934	8,228,822	3,581,531	5,826,922	8,900,019	14,839,000	18,431,937	22,266,800	19,369,277	22,665,434	17,736,837	22,281,542	21,509,384
Total Liabilities	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	3,995,973	7,253,690	5,968,269	7,737,314	4,413,213	14,390,855	4,875,981
Shares Outstanding	1,887,535	1,061,533	518,296	3,026,028	2,471,656	678,002	8,994,920	7,878,568	7,294,005	2,739,315	2,181,912	2,141,782	2,078,271	2,078,271	2,078,271	1,054,043	52,623,407	32,578,475	31,383,632	21,432,415
Shares Outstanding Diluted	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Weighted Avg Shares Diluted	1,510,401	334,719	313,242	2,595,728	1,797,774	502,900	8,702,951	7,587,851	4,001,456	2,159,063	2,164,656	2,107,583	2,078,271	1,446,007	1,787,235	1,053,760	n/a	n/a	n/a	n/a
Weighted Avg Shares Basic	1,510,401	334,719	313,242	2,595,728	1,797,774	502,900	8,702,951	7,587,851	4,001,456	2,159,063	2,164,656	2,107,583	2,078,271	1,446,007	1,787,235	1,053,760	42,356,752	472,343	459,289	426,883

Audit Trail

NCAV Audit

Official-source inputs remain linked to filing provenance. Derived values are labeled as such.

Input	Value	Source concept	Filing period	Confidence	Provenance
Current Assets	5,375,099USD	us-gaap:AssetsCurrent	2026-03-31	1.00	sec/companyfacts/cik=0000890821/companyfacts.json D:\Projects\The Data Vault\objects\sec\companyfacts\cik=0000890821\companyfacts.json
Total Liabilities	n/a	derived	2026-03-31	n/a	n/a
Cash	n/a	derived	2026-03-31	n/a	n/a
Shares Outstanding	1,887,535	us-gaap:CommonStockSharesOutstanding	2026-03-31	1.00	sec/companyfacts/cik=0000890821/companyfacts.json D:\Projects\The Data Vault\objects\sec\companyfacts\cik=0000890821\companyfacts.json
NCAV	n/a	derived	2026-03-31	n/a	company-evidence-v1 \| total_current_assets - total_liabilities
NCAV per share	n/a	derived	2026-03-31	n/a	company-evidence-v1 \| NCAV / shares_outstanding
Margin of Safety	44.3%	derived	2026-03-31	n/a	gnni_publication_pack \| internal_discount

NCAV could not be calculated because one or more inputs are missing.

Source Provenance

Data Source: Data Vault
Data Vault Root
CIK: 0000890821
Company ID: n/a
Selected Annual Source: n/a
Selected Quarterly Source: n/a
Statement Extractor: companyfacts-screener-v1
View Extractor: companyfacts-screener-v1
Source Accession Count: 22
Imported At: 2026-07-04T23:04:28+00:00
Rendered At: 2026-07-05T09:06:29+00:00

Run Audit

Mary Run: 1ec055d81d1a42a39490a83bb9e1f22f
Mary As Of: 2026-07-03
Accession: 0001493152-26-023353
CIK: 0000890821
Mary Filing Date: 2026-05-15
Filing Currency: USD
Internal Discount: 44.3%
Source State: Verified
Market Context: Not Displayed
Market Policy: internal_only_not_redistributed
Share Trend: Not Evaluated
Dilution: Needs Review

mary_run=1ec055d81d1a42a39490a83bb9e1f22f; mary_as_of=2026-07-03; mary_filing_date=2026-05-15; mary_accession=0001493152-26-023353; mary_cik=0000890821; gnni_supporting_filing_date=2026-05-15; internal_discount=0.443083; mary_reason=Mary's deterministic net-net screen flagged this candidate. The internal discount is shown; raw market-data fields are not published in this pilot.

Back to Register Archive